Author

Cécile Fabron

Observed names: C Fabron, C. Fabron, Cecile Fabron, Fabron, Cécile

Institution: Cemka-Eval (France)

Observed institution: Cemka-Eval (France)

ORCID: 0000-0003-2500-6444

Observed ORCID: 0000-0003-2500-6444

OpenAlex ID: A5016435705

Economic Evaluation of Telerehabilitation: Systematic Literature Review of Cost-Utility Studies

2023 · Sandrine Baffert, Nawale Hadouiri, et al. · JMIR Rehabilitation and Assistive Technologies · 33

Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database

2020 · Jérôme Boursier, Sanatan Shreay, et al. · EClinicalMedicine · 30

Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

2019 · Martine Hoogendoorn, Isaac Corro Ramos, et al. · International Journal of COPD · 9

Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France

2021 · Teddy Linet, Laurie Lévy-Bachelot, et al. · The European Journal of Contraception & Reproductive Health Care · 6

Out-of-Pocket Expenses in Households of People Living with Obesity in France

2023 · Cécile Fabron, Martine Laville, et al. · Obesity Facts · 5

NAFLD/NASH patients with compensated cirrhosis (CC) had a high prevalence of comorbidities, substantial liver disease progression, and increased annual number of hospitalizations and associated costs in France: a PMSI database analysis

2018 · J. Boursier, C. Fabron, et al. · Journal of Hepatology · 3

NASH/NAFLD patients with end stage liver disease experienced high inpatient hospitalization costs and substantial disease progression: Results of a French national database on hospital care analysis

2018 · J. Boursier, C. Fabron, et al. · Journal of Hepatology · 2

France's competitiveness in global pharmaceutical research: The situation is improving

2021 · Anne d’Andon, Ariane Galaup, et al. · Therapies · 1

PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX Other Contraceptive Methods Based on Real Life DATA in France

2020 · T. Linet, L. Levy Bachelot, et al. · Value in Health · 1

THU-299-Increased risk of mortality with liver disease progression in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients: An analysis of French national hospital care

2019 · Jerome Boursier, Jeremy Fraysse, et al. · Journal of Hepatology · 1

Cost-effectiveness of the fixed-dose combination tiotropium + olodaterol based on the DYNAGITO trial results

2018 · Martine Hoogendoorn, Isaac Corro Ramos, et al. · European Respiratory Journal · 1

EE154 Reassessment of a Cost-Effectiveness Analysis of Etonogestrel Implant Compared to Other Contraceptive Methods Based on Real Life Data in France

2022 · L Dumon, C Gouzy, et al. · Value in Health

Etude coût-utilité d'une stratégie vaccinale dans la prévention contre les infections à méningocoques de sérogroupe C

2022 · S. Fievez, M. Chechoi, et al. · Revue d Épidémiologie et de Santé Publique

Prs49 - Cost-effectiveness of the Fixed-dose Combination Tiotropium + Olodaterol Versus Tiotropium Based on the Dynagito Trial Results in France

2018 · L. Luciani, M. Hoogendoorn, et al. · Value in Health

Conséquences économiques du suivi biologique et des complications médicales en lien avec l’utilisation des anticoagulants injectables en France

2016 · P. Paubel, M. Cousin, et al. · Journal des Maladies Vasculaires

Works count: 16

Citation count: 92

H-index: 5

I10-index: 2